Analysis of M1 and M2 tumor associated macrophages in tongue squamous cell carcinomas by Agarbati, Silvia et al.
5th National and 1st International Symposium 87
 
Poster presentations
Analysis of M1 and M2 tumor associated 
macrophages in tongue squamous cell  
carcinomas
Silvia Agarbati1*, Marco Mascitti1, Giuseppina Campisi2, Lorenzo Lo 
Muzio3, Corrado Rubini1, Francesca Fazioli1
1Department of Clinical and Molecular Sciences, Polytechnical University of Marche, Ancona, Italy
2Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy
3Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
*silvia.agarbati@virgilio.it
AIM
Tumor associated macrophages (TAMs) are the dominant leukocyte pop-
ulation found in the tumor microenvironment and their mobilization into 
tumor tissues is a critical event in tumor initiation, growth, and develop-
ment. TAMs are a heterogeneous population of innate myeloid cells and 
take on various phenotypes depending on the context of the molecular 
stimuli from the microenvironment. Basically, there are two main recog-
nized categories: classically-activated pro-inflammatory M1 macrophages 
(expressing the CD11c antigen) and alternatively-activated anti-inflammatory 
M2 macrophages (expressing the CD163 antigen). Although TAMs have been 
detected in head and neck cancers, little is known about their phenotype in 
the context of the tongue squamous cell carcinoma (TSCC), which have the 
highest incidence in maxillofacial malignant tumors. The aim of the present 
retrospective study was to characterize the macrophage polarization in low 
grade (G1) and high grade (G3) TSCC, and to examine the importance of 
their relative localization (tumor stroma, inflammation area or tumor nest) on 
tumor-promoting capabilities and tumor-prognostic relevance.
MATERIALS AND METHODS
This study included surgical specimens obtained from 71 patients with TSCC 
(36 graded as G1 and 35 graded as G3). 4-µm serial sections from forma-
lin-fixed, para!n embedded blocks were cut for each case and mounted on 
poly-L-lysine-coated glass slides. The sections were incubated for one hour at 
room temperature, with anti-CD163 monoclonal antibody (MA5-11458 clone 
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10D6 Thermo Scientific, dilution 1:100) and anti-CD11c monoclonal antibody 
(ab52632 clone EP1347Y Abcam, dilution 1:200). Immunohistochemical stain-
ing of TAMs was evaluated both in inflammatory infiltrate and tumor stroma. 
To evaluate the expression of CD11c and CD163, the percentage of positive 
cells was scored as 0 (< 10%), 1 (10-25%), 2 (26-50%), and 3 (> 50%). The 
staining intensity was scored as 0 for negative, 1 for weak, 2 for moderate, 
and 3 for intense expression. 
RESULTS
Infiltration of CD11c+ (M1) or CD163+ (M2) TAMs in the tumor nest was not 
associated with any clinicopathological features. On the contrary, CD11c+ 
and CD163+ samples were significantly more numerous in G3 group, both in 
terms of extension and intensity of staining. In addition, a positive correlation 
was found between inflammatory-CD11c and stromal-CD163 expression, 
both in extension and intensity of staining. Moreover, Kaplan-Meier analysis 
showed better disease-free survival (DFS) in G3 patients with inflammato-
ry-CD11c expression, while inflammatory-CD163 expression was associated 
with a worse DFS. Finally, patients with stromal-CD163 expression showed 
better DFS in both G1 and G3 patients.
DISCUSSION
These findings highlight the importance of analyzing the phenotype of TAMs 
(CD11c+ and CD163+) both in inflammatory infiltrate and tumor stroma as 
a new promising prognostic marker in TSCC.
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